首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1789408

鮭魚抑鈣素市場：按配方、按應用、按性別、按年齡層、按最終用戶、按配銷通路、按地區

Calcitonin Salmon Market, By Formulation, By Application, By Gender, By Age Group, By End User, By Distribution Channel, By Geography

出版日期: 2025年07月18日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年鮭魚抑鈣素市場價值估計為 4.522 億美元，預計到 2032 年將達到 7.101 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.522億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	6.60%	2032年預測	7.101億美元

全球鮭魚抑鈣素市場是一個專注於鮭魚來源合成抑鈣素的特種藥物市場，這是一種重要的治療藥物，主要用於治療骨質疏鬆症、佩吉特氏症和高鈣血症。鮭魚來源抑鈣素是天然抑鈣素降鈣素的合成版本，與人源抑鈣素相比，效力更強，半衰期更長，因此在調節鈣穩態和骨骼代謝方面特別有效。

該市場涵蓋各種劑型，包括滴鼻劑、注射液和新型給藥系統，以滿足全球不同患者群的需求。骨質疏鬆症的盛行率不斷上升，尤其是在老年人群中，以及人們對骨骼健康管理意識的不斷增強，使抑鈣素魚降鈣素成為現代治療通訊協定的重要組成部分。醫療保健提供者越來越認知到疼痛管理和骨骼密度的雙重益處，從而推動了已開發經濟體和新興經濟體的市場發展。持續研究新的應用、改進的劑型和聯合治療，可以提高患者的依從性和治療效果，進一步支持了市場的成長軌跡，使抑鈣素魚降鈣素成為內分泌學和整形外科醫學的關鍵治療藥物。

市場動態

全球抑鈣素鮭魚市場主要受世界人口快速老化所驅動，骨質疏鬆症影響全球超過2億人，對有效的骨骼健康治療方案的需求龐大。醫療保健支出的不斷成長，尤其是在已開發地區，促進了抑鈣素鮭魚等專科治療的普及，同時，醫療保健專業人員和患者對預防性骨骼保健意識的不斷增強也加速了市場滲透。該市場受惠於持續的研發活動，這些研發活動專注於改善藥物輸送機制、減少副作用並提高療效，製藥公司也大力投資新型製劑和聯合治療。

然而，市場成長面臨重大障礙，包括具有相當甚至更好療效的替代療法的興起，如雙磷酸鹽、Denosumab和新型合成代謝藥物，這些可能會限制抑鈣素的市場佔有率。監管挑戰和安全問題，特別是對長期使用和潛在心血管風險的監管審查力度加大，正在影響處方模式和市場信心。此外，一些地區高昂的治療費用和有限的保險覆蓋範圍限制了患者的治療機會，而成熟市場的學名藥競爭正在影響定價策略。儘管存在這些挑戰，但新興市場仍然存在巨大的商機，不斷發展的醫療保健基礎設施和不斷成長的可支配收入正在創造新的患者群體。經皮貼片和緩釋性等創新給藥系統的開發提供了巨大的成長潛力，其在疼痛管理中的廣泛應用以及在其他鈣相關疾病中的潛在應用為市場擴張和多樣化提供了有希望的途徑。

本次調查的主要特點

本報告對全球鮭魚抑鈣素市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，概述了全球抑鈣素鮭魚市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球抑鈣素鮭魚市場的各種策略矩陣，相關人員將更容易做出決策。

AdvaCare Pharma
VTV Formulations
B JOSHI AGROCHEM PHARMA
Sanofi SA
Viatris Inc（formerly Mylan）
Fresenius Kabi AG
Sun Pharmaceutical Industries Ltd
Reddy's Laboratories Ltd
Cipla Ltd
Hikma Pharmaceuticals plc
Endo International plc
Asahi Kasei Pharma Corporation
Anhui Anke Biotechnology（Group）Co. Ltd
Hybio Pharmaceutical Co. Ltd
Leucadia Pharmaceuticals

第 12 章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8273

Calcitonin Salmon Market is estimated to be valued at USD 452.2 Mn in 2025 and is expected to reach USD 710.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 452.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.60%	2032 Value Projection:	USD 710.1 Mn

The global calcitonin salmon market is estimated to be valued at USD 452.2 Mn in 2025 and is expected to reach USD 710.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. the global calcitonin salmon market represents a specialized pharmaceutical segment focused on synthetic calcitonin derived from salmon, a crucial therapeutic agent primarily utilized in treating osteoporosis, Paget's disease, and hypercalcemia. Calcitonin salmon, a synthetic version of the naturally occurring hormone calcitonin, exhibits enhanced potency and longer half-life compared to human calcitonin, making it particularly effective in regulating calcium homeostasis and bone metabolism.

This market encompasses various formulations including nasal sprays, injectable solutions, and emerging delivery systems, catering to diverse patient populations worldwide. The increasing prevalence of osteoporosis, particularly among aging populations, coupled with rising awareness about bone health management, has positioned calcitonin salmon as an essential component in modern therapeutic protocols. Healthcare providers increasingly recognize its dual benefits in pain management and bone density preservation, driving market expansion across developed and emerging economies. The market's growth trajectory is further supported by ongoing research into novel applications, improved formulations, and combination therapies that enhance patient compliance and therapeutic outcomes, establishing calcitonin salmon as a cornerstone treatment in endocrinology and orthopedic medicine.

Market Dynamics

the global calcitonin salmon market is primarily driven by the rapidly aging global population, with osteoporosis affecting over 200 million people worldwide, creating substantial demand for effective bone health treatments. Rising healthcare expenditure, particularly in developed regions, facilitates increased accessibility to specialized treatments like calcitonin salmon, while growing awareness about preventive bone care among healthcare professionals and patients accelerates market adoption. The market benefits from continuous research and development activities focused on improving drug delivery mechanisms, reducing side effects, and enhancing therapeutic efficacy, with pharmaceutical companies investing significantly in novel formulations and combination therapies.

However, market growth faces significant restraints including the emergence of alternative treatments such as bisphosphonates, denosumab, and newer anabolic agents that offer comparable or superior efficacy profiles, potentially limiting calcitonin salmon's market share. Regulatory challenges and safety concerns, particularly regarding long-term use and potential cardiovascular risks, have led to increased scrutiny from regulatory authorities, impacting prescription patterns and market confidence. Additionally, high treatment costs and limited insurance coverage in certain regions restrict patient access, while generic competition in mature markets pressures pricing strategies. Despite these challenges, substantial opportunities exist in emerging markets where increasing healthcare infrastructure development and rising disposable incomes create new patient populations. The development of innovative delivery systems, including transdermal patches and sustained-release formulations, presents significant growth potential, while expanding applications in pain management and potential use in other calcium-related disorders offer promising avenues for market expansion and diversification.

Key Features of the Study

This report provides in-depth analysis of the global calcitonin salmon market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global calcitonin salmon market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AdvaCare Pharma, VTV Formulations, B JOSHI AGROCHEM PHARMA, Sanofi S.A, Viatris Inc (formerly Mylan), Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Hybio Pharmaceutical Co. Ltd, and Leucadia Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global calcitonin salmon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global calcitonin salmon market

Market Segmentation

Formulation Insights (Revenue, USD Mn, 2020 - 2032)
- Intranasal
- Subcutaneous
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Osteoporosis
- Paget's disease of bone
- Hypercalcemia
- Multiple myeloma
- Others (Bone Pain Alleviation)
Gender Insights (Revenue, USD Mn, 2020 - 2032)
- Female
- Male
Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Adults
- Geriatric
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Homecare Settings
- Ambulatory Surgical Centers
- Long-Term Care Facilities
- Others (Academic and Research Institutes, etc.)
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- AdvaCare Pharma
- VTV Formulations
- B JOSHI AGROCHEM PHARMA
- Sanofi S.A
- Viatris Inc (formerly Mylan)
- Fresenius Kabi AG
- Sun Pharmaceutical Industries Ltd
- Reddy's Laboratories Ltd
- Cipla Ltd
- Hikma Pharmaceuticals plc
- Endo International plc
- Asahi Kasei Pharma Corporation
- Hybio Pharmaceutical Co. Ltd
- Leucadia Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Calcitonin Salmon Market, By Formulation
- Global Calcitonin Salmon Market, By Application
- Global Calcitonin Salmon Market, By Gender
- Global Calcitonin Salmon Market, By Age Group
- Global Calcitonin Salmon Market, By End User
- Global Calcitonin Salmon Market, By Distribution Channel
- Global Calcitonin Salmon Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Calcitonin Salmon Market, By Formulation, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Calcitonin Salmon Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Paget's disease of bone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hypercalcemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Multiple myeloma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Bone Pain Alleviation)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Calcitonin Salmon Market, By Gender, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Calcitonin Salmon Market, By Age Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Calcitonin Salmon Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Long-Term Care Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Academic and Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Calcitonin Salmon Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Calcitonin Salmon Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

AdvaCare Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
VTV Formulations
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B JOSHI AGROCHEM PHARMA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viatris Inc (formerly Mylan)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reddy's Laboratories Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cipla Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asahi Kasei Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Anhui Anke Biotechnology (Group) Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hybio Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Leucadia Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies